Biocytogen Pharmaceuticals (Beijing) Co., Ltd. manufactures biological products and provides related biological services. It operates through the following segments: Gene Editing Services, Pre-Clinical Pharmacology and Efficacy Evaluation, Animal Models Selling, Antibody Development, and Innovative Drugs Development. The Gene Editing Services segment provides gene editing services. The Pre-Clinical Pharmacology and Efficacy Evaluation segment involves in the provision of pre-clinical pharmacology service for drug efficacy and toxicity evaluation. The Animal Models Selling segment breeds and sells the animal models for the external and internal use. The Antibody Development segment includes one-stop solution from antibody preparation to IND filing for the customer. The Innovative Drugs Development consists of research and developing drugs with a focus on oncology and autoimmune disease therapeutics. The company was founded by Yue Lei Shen on November 13, 2009 and is headquartered in Beijing, China.

Guangdong Yaokang Biotechnology Co., Ltd., established on 2018-10-26, Business scope includes general items:Manufacturing of experimental analysis instruments;Manufacturing of special equipment(Manufacture of licensed professional equipment not included);Experimental animal litter production;Experimental analysis instrument sales;Laboratory Animal Bedding Sales;Laboratory animal cage sales;Engineering and Technology Research and Experimental Development;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Natural science research and experimental development;Medical Research and Experimental Development;Information Consulting Service(Not including licensing information consulting services);Sales of Class I Medical Devices;Domestic trade agent;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Inspection and testing service;pharmaceutical production;Experimental animal production;Experimental animal management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Saiye (Suzhou) Biotechnology Co., Ltd, established on 2011-05-27, Business scope includes bioengineering technology development,technical consulting,technology transfer,Technical Services,Research and development of biomedical materials and products;Distribution of experimental equipment;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Biositu Jiangsu Gene Biotechnology Co., Ltd., established on 2014-10-14, Business scope includes licensed projects:Offshore trade operation;Experimental animal production;Experimental animal management(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology promotion and application services;Medical Research and Experimental Development;Technology Import and Export;Import and export agency;rental service(Licensed rental services not included);Non-residential real estate leases(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Omo Biotechnology (Guangzhou) Co., Ltd., established on 2017-12-28, Business scope includes human science research,to develop;Natural science research and experimental development;Pharmaceutical Research Services;Medical technology research and development;drug development;Medical Research and Experimental Development;Biomedical Technology Research;Health Sciences Program Research,to develop;Biopharmaceutical Manufacturing;blood product manufacturing;Preparation of cell preparations and related products;Sanitary materials and medical supplies manufacturing;medical diagnosis,Monitoring and treatment equipment manufacturing;medical diagnosis,Monitoring and treatment equipment wholesale;medical diagnosis,Monitoring and treatment equipment retail;Manufacturing of chemical preparations;Chemicals,Biological product(Contains vaccine)wholesale

Zhejiang Ketu Medical Technology Co., Ltd., established on 2018-01-15, Business scope includes medical inspection technology,Pharmacy,Technology development for medical research;Technology Development of Gene Sequencing for Drug Evaluation,technical consulting,Technical Services;medical instruments,In vitro diagnostic reagents,biological reagent(Removal of hazardous chemicals and precursor chemicals),Technical development of machinery and equipment;Development of new anticancer drugs;Drug Preclinical Development;Drug Clinical Development;Biomarker R&D;Technical services in the field of biotechnology,technical consulting,Technical testing,Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Nanjing University Science and Technology Park Development Co., Ltd., established on 2011-04-22, The scope of business includes the construction of high-tech parks,Operation and Management,Venture Capital,Technical Services,technology transfer,Socioeconomic information consultation,Realtor,property management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Real estate development and management;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:For-profit private training institutions engaged in scientific and technological training(In addition to the subject classes for primary and middle school students,Language and cultural education and training);Educational Consulting Services(Education and training activities that do not include licensing approval);Business Management Consulting;Information Technology Consulting Services;Intellectual Property Services(Trademark agency service,Except for patent agency services);Technology intermediary service;Technology promotion and application services;Entrepreneurial Space Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Non-Major Crop Seed Production;Wholesale of edible agricultural products;Retailing of Edible Agricultural Products;Sales of agricultural and sideline products;Fresh Meat Retail;Fresh Meat Wholesale;internet sales(Except for products that require a license for sale);Tea set sales;Landscaping engineering construction;Conference and Exhibition Services;Calculator Equipment Sales;software development;food business(Only sell prepackaged food)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Keyuan Pharmaceutical is a pharmaceutical company that engages in the manufacture of pharmaceuticals. Tablets, fluids, ointments, and injectables are among their offerings. Its goal is to improve people's lives by enabling them to achieve more, feel better, and live longer. They have technological machinery, skilled and motivated individuals, and management systems that can handle both quantity and quality of work. They are looking for new ways to improve their performance, raise their integrity to a level of excellence, implement their initiatives, and achieve their goals.

Horizon Discovery Group PLC is a UK life science company that uses gene editing and gene modulation platforms to produce cells, applying them in research and clinical applications that advance human health. The Company’s gene editing and gene modulation platform, are able to alter almost any DNA sequence or RNA transcription, has generated a catalogue of over 1,000,000 cell and reagent products that help researchers recapitulate the genetic and protein anomalies found in diseases like cancer. These models have been adopted by c12, 000 organizations to better understand of the predictors and drivers of disease and drug response, and by Horizon in a range of services offered to customers, as well as in the Company’s own research R&D pipeline.